2,505
Views
1
CrossRef citations to date
0
Altmetric
Pneumococcal

Safety and immunogenicity of a 15-valent pneumococcal conjugate vaccine in Japanese healthy infants: A Phase I study (V114-028)

, , , , , & show all
Article: 2180973 | Received 22 Dec 2022, Accepted 13 Feb 2023, Published online: 07 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Alvino Maestri, Su Eun Park, Fiona Fernandes, Zhongyi “Lucy” Li, Yae-Jean Kim, Yun-Kyung Kim, Jin Lee, Ji Young Park, Dong Hyun Kim, GyongSeon Yang, Hyunjung Lim, Jin Oh Kim, Robert Lupinacci, Tina M. Sterling, Marissa Wilck, Alejandra Esteves-Jaramillo & Natalie Banniettis. (2024) A phase 3, single-arm, open-label study to evaluate the safety, tolerability, and immunogenicity of a 15-valent pneumococcal conjugate vaccine, V114, in a 3+1 regimen in healthy infants in South Korea (PNEU-PED-KOR). Human Vaccines & Immunotherapeutics 20:1.
Read now